Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Principia Biopharma Inc. (PRNB) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/18/2018 8-K Resignation/termination of a director
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : September 13, 2018 PRINCIPIA BIOPHARMA INC. Delaware 001-38653 26-3487603 400 East Jamie Court, Suite 302 South San Francisco, California 94080 Registrant's telephone number, including area code: 416-7700 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act )...",
"Amended and Restated Certificate of Incorporation of the Company",
"Amended and Restated Bylaws of the Company"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy